TABLE 1

Characteristics of Medalist study participants

Male (%)47.0 (192)
A1C (%)7.3 ± 1.1
Age (years)67.2 ± 7.4
Age at diagnosis (years)11.0 ± 6.5
Duration (years)56.2 ± 5.8
BMI (kg/m2)26.0 ± 5.1
C-peptide (nmol/l)0.07 ± 0.12
Cholesterol (mmol/l)4.2 ± 0.9
Calculated HDL (mmol/l)1.6 ± 0.5
LDL (mmol/l)2.2 ± 0.6
Triglycerides (mmol/l)0.9 ± 0.5
Insulin dose (u/kg)0.46 ± 0.2
Family history of diabetes
    Any diabetes29.7 (122)
    Type 1 diabetes12.9 (53)
DR3*38.8 (116)
DR4*52.0 (156)
DR3 or DR4*93.7 (295)
DR3/4*39.1 (118)
IA2 or GAD*29.7 (111)
IA2*14.9 (56)
GAD*18.4 (69)
Proliferative diabetic retinopathy*55 (163)
Microalbuminuria (ACR <7.91)*13.1 (45)
Neuropathy (MNSI >2)*60.6 (183)
Cardiovascular disease*48.3 (160)
  • Data are means ± SD or % (n).

  • *Percentages reflect calculations done on data available. ACR, albumin-to-creatinine ratio; MNSI, Michigan Neuropathy Screening Instrument.